How to Survive a DEA Inspection Series: "DEA and Your Prescription"

MentorHealth
Duration: 60 Minutes
Instructor: Carlos M. Aquino
Webinar Id: 800155

Recorded

$225.
One Attendee
Refund Policy

Overview:

Today the media has placed a great emphasis on practitioners and the prescribing of controlled substances. In some cases, the practitioner has been targeted and labeled as a "Pill Mill" or a "Drug Dealers" by the public stories.

Every practitioner who prescribes any drug substance that is documented as part of a treatment plan should protect themselves by knowing the federal laws and regulations imposed by the Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion).

Areas Covered In the Session: Class participants, especially practitioners and their medical staff, will get a better understanding of DEA regulations pertaining to Schedules II through V drugs that are administered, dispensed, or prescribed by a practitioner as part of a treatment plan.

The presentation will:

  • Identify the role and actions of DEA Diversion in enforcing federal laws and regulations for the administering, dispensing and prescribing of controlled substances as part of a treatment plan. The actions include criminal and administrative actions on practitioners who prescribe controlled substances as part of a patient treatment plan.
  • Discuss the importance of maintaining a good patient chart that will show the diagnosis for the prescribing of controlled substances as part of a treatment plan. This includes the use of a patient agreement and the steps leading to a treatment plan.
  • Review DEA regulations pertaining to the administering, dispensing and prescribing of controlled substance by practitioners. This includes DEA electronic prescriptions, the DEA regulation pertaining to a 90-day supply of a Schedule II drug, and other dispensing regulations.

Who will Benefit:
  • Compliance Managers
  • Quality Managers
  • DEA Professionals
  • Manufacturers
  • Distributers

Speaker Profile
Carlos M. Aquino brings 36 years of experience of handling illicit and pharmaceutical controlled substances and regulated chemicals. His testimonial ability, both in federal and state courts, is proof of his investigative experience and skills. Carlos has 12 years of experience working for Philadelphia DEA Diversion Group, which is responsible for initiating prosecutions of those DEA registrants who violate the federal Controlled Substances Act or DEA regulations pertaining to handling these substances. This has included eight years as a Diversion Investigator and four years as a Group Supervisor. During his time at the DEA, he performed numerous regulatory inspections of manufacturers, distributors, importers/exporters, physicians, researchers, and pharmacies in order to determine their compliance with the federal laws and DEA regulations pertaining to controlled substances in Schedules II through V and regulated chemicals.

In addition to the above, Carlos has over 20 years of experience working for various law enforcement agencies including the Philadelphia Police. Carlos has a BA in Criminal Justice and has taught numerous courses during his time at the DEA.

He is skilled in interpreting the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR), assisting the pharmaceutical industry with compliance, and preparing and submitting Drug Enforcement Administration (DEA) Forms 41, 104, 106, 222, 236, 486.


You Recently Viewed